Chemours Company Faces Class Action Lawsuit Over Opteon Product Demand
Oct 23, 2026
A law firm filed a class action against Chemours, alleging overstated demand for its Opteon products led to unreliable financial guidance. Investors buying securities during the specified period are urged to join the case before the December deadline.
Show all 32 updates